← Leaderboards
Ihn Sik Seong
Massachusetts General Hospital
$4,586,328
Attributed
$5,550,236
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,550,236 · 4
By mechanism
R01$5,379,236 · 3
R03$171,000 · 1
Top collaborators
- Vanessa C Wheeler3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Junfeng Wang$753,630
- Keith W Miller$21,650,712
- Biju Parekkadan$9,663,657
- Zhaoda Zhang$4,338,002
- Arno W Tilles$4,868,169
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesInduced Pluripotent Stem CellNeuronsSeriesHuntington DiseaseMutationModificationLengthProteinsCag RepeatInheritedPathogenesisComplexNeurodegenerative DisordersBiochemicalCellsTherapeutic InterventionAmino AcidsBindingAffectAllelesNerve Stem CellNervous System DisorderMolecular
Grant awards (14)
Dissecting the role of DNA Ligase 1 in Huntington's disease$657,103
R01 · FY2025 · NS
Dissecting the role of DNA Ligase 1 in Huntington's disease$640,064
R01 · FY2024 · NS
An Alternative Isoform of RRM2B as a Genetic Modifier in Huntington's Disease$382,956
R01 · FY2024 · NS · contact PI
Dissecting the role of DNA Ligase 1 in Huntington's disease$630,650
R01 · FY2023 · NS
An Alternative Isoform of RRM2B as a Genetic Modifier in Huntington's Disease$394,800
R01 · FY2023 · NS · contact PI
An alternative isoform of RRM2B as a genetic modifier in Huntington's disease$394,800
R01 · FY2022 · NS · contact PI
An alternative isoform of RRM2B as a genetic modifier in Huntington's disease$394,800
R01 · FY2021 · NS · contact PI
An alternative isoform of RRM2B as a genetic modifier in Huntington's disease$394,800
R01 · FY2020 · NS · contact PI
Discovery of histone methyltransferase interactions with full-length huntingtin$85,500
R03 · FY2019 · NS · contact PI
Discovery of histone methyltransferase interactions with full-length huntingtin$85,500
R03 · FY2018 · NS · contact PI
Effects of PolyQ Expansion on Full-length Huntingtin Protein in HD$376,417
R01 · FY2015 · NS · contact PI
Effects of PolyQ Expansion on Full-length Huntingtin Protein in HD$372,653
R01 · FY2014 · NS · contact PI
Effects of PolyQ Expansion on Full-length Huntingtin Protein in HD$363,242
R01 · FY2013 · NS · contact PI
Effects of PolyQ Expansion on Full-length Huntingtin Protein in HD$376,951
R01 · FY2012 · NS · contact PI